Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Phototherapy in Progressive Vitiligo
NCT04237103Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2023
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in Vitiligo, sponsored by Centre Hospitalier Universitaire de Bordeaux. Started May 2023; status: completed.
02
Drugs
methotrexate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04237103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237103.